BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 30181084)

  • 1. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood and Anticoagulation Management in Extracorporeal Membrane Oxygenation for Surgical and Nonsurgical Patients: A Single-Center Retrospective Review.
    Buscher H; Vukomanovic A; Benzimra M; Okada K; Nair P
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):869-875. PubMed ID: 28082026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact and Statistical Analysis of a Multifaceted Anticoagulation Strategy in Children Supported on ECMO: Performance and Pitfalls.
    Kessel AD; Kline M; Zinger M; McLaughlin D; Silver P; Sweberg TM
    J Intensive Care Med; 2017 Jan; 32(1):59-67. PubMed ID: 26319579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
    Fitousis K; Klasek R; Mason PE; Masud F
    Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.
    Al-Jazairi A; Raslan S; Al-Mehizia R; Dalaty HA; De Vol EB; Saad E; Alanazi M; Owaidah T
    Ann Pharmacother; 2021 May; 55(5):592-604. PubMed ID: 32959678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HAT Score-A Simple Risk Stratification Score for Coagulopathic Bleeding During Adult Extracorporeal Membrane Oxygenation.
    Lonergan T; Herr D; Kon Z; Menaker J; Rector R; Tanaka K; Mazzeffi M
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):863-868. PubMed ID: 27842949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Initial Anticoagulation Targets on Bleeding and Thrombotic Complications for Patients With Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.
    Cercone JL; Kram SJ; Trammel MA; Rackley CR; Lee HJ; Merchant J; Kram BL
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3561-3569. PubMed ID: 35691853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
    Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
    Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
    Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
    J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
    Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
    J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation.
    Sulkowski JP; Preston TJ; Cooper JN; Duffy VL; Deans KJ; Chicoine LG; Minneci PC
    J Extra Corpor Technol; 2014 Mar; 46(1):69-76. PubMed ID: 24779122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anticoagulation protocol for use after congenital cardiac surgery.
    Nair AG; Oladunjoye OO; Trenor CC; LaRonde M; van den Bosch SJ; Sleeper LA; VanderPluym C; Emani SM; Kheir JN
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):343-352.e4. PubMed ID: 29706371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy.
    Liu Y; Yuan Z; Han X; Song K; Xing J
    Hamostaseologie; 2023 Jun; 43(3):171-178. PubMed ID: 35882351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
    Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
    Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
    Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
    Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.